Fennec Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
FENC Nasdaq 8731 https://fennecpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - Sep 7th, 2023 9:59 am
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update - Aug 3rd, 2023 9:59 am
Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 - Jul 31st, 2023 9:30 am
Fennec Announces Results of Annual Meeting - Jun 12th, 2023 9:00 pm
Retail investors who hold 38% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) gained 13%, institutions profited as well - Jun 8th, 2023 6:53 pm
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients - Jun 6th, 2023 9:44 am
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update - May 11th, 2023 10:01 am
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023 - May 8th, 2023 10:15 am
When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable? - Apr 28th, 2023 1:26 pm
Investors in Fennec Pharmaceuticals (NASDAQ:FENC) have made a notable return of 52% over the past three years - Apr 1st, 2023 12:12 pm
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients - Mar 31st, 2023 12:03 pm
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results - Mar 30th, 2023 9:55 am
7 Biotech Stocks Sitting in the Sweet Spot - Mar 24th, 2023 10:30 am
Why Earnings Season Could Be Great for Adherex Technologies (FENC) - Feb 23rd, 2023 1:44 pm
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA - Jan 31st, 2023 11:00 am
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients - Jan 25th, 2023 12:19 pm
Institutions own 28% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares but individual investors control 55% of the company - Dec 17th, 2022 2:55 pm
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update - Nov 11th, 2022 12:10 pm
Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Are Analysts Optimistic? - Nov 1st, 2022 2:28 pm
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States - Oct 17th, 2022 12:00 pm